Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Central Serous Chorioretinopathy. Data from NIH RePORTER, last 36 months.
Central Serous Chorioretinopathy has emerging NIH research funding with 1 grant totaling $554K.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Central Serous Chorioretinopathy. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
9 clinical trials registered but no NIH-funded clinical or translational research grants found for central serous chorioretinopathy. Trials may be industry-sponsored or funded through non-NIH sources.
6 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for central serous chorioretinopathy. Existing research activity suggests this may be a viable area for grant applications.
8 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for central serous chorioretinopathy. Existing research activity suggests this may be a viable area for grant applications.
8 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for central serous chorioretinopathy. Existing research activity suggests this may be a viable area for grant applications.
16 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for central serous chorioretinopathy. Existing research activity suggests this may be a viable area for grant applications.